Healthy women needed to compare two tablet versions of experimental drug

NCT ID NCT07544628

Recruiting now Knowledge-focused Sponsor: Bristol-Myers Squibb Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests whether two different tablet forms of the drug navlimetostat are processed the same way in the body. It involves 64 healthy adult women who are not able to become pregnant. Participants will receive both tablet versions at different times to compare drug levels and safety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: navlimetostat (BMS-986504)

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY PARTICIPANTS

Contacts and locations

Locations

CenExel iResearch - Decatur
RECRUITING

Decatur, Georgia, 30030, United States
Local Institution - 0001
WITHDRAWN

Austin, Texas, 78744, United States
Local Institution - 0003
WITHDRAWN

Decatur, Georgia, 30030, United States
Local Institution - 0004
NOT_YET_RECRUITING

Austin, Texas, 78744, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.